Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	ZBHZimmer Biomet	STESteris	RVTYRevvity
Snapshot
Price	$96.12	$234.11	$114.66
Market cap	$17.28B	$21.27B	$12.69B
Valuation
P/E	24.4x	29.2x	53.7x
Forward P/E	28.6x	22.8x	60.1x
Growth
Revenue growth	9.2%	8.7%	4.8%
EPS growth	-14.6%	27.9%	-10.7%
Profitability
Net margin	9.1%	13.2%	8.3%
ROE	6.0%	11.1%	3.3%
Balance sheet & cash
Debt / equity	0.59x	0.27x	0.44x
Free cash flow yield	7.5%	5.4%	5.1%
Dividend yield	1.0%	1.2%	0.3%
Verdict
Investment rating	Neutral· 50	Favorable· 59	Weak· 33

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	ZBHtoday $96	STEtoday $234	RVTYtoday $115
2027	$73.53 – $107.85+12% CAGR	$224.66 – $329.50+41% CAGR	$87.71 – $128.65+12% CAGR
2028	$75.00 – $110.00+7% CAGR	$287.45 – $421.59+34% CAGR	$89.47 – $131.22+7% CAGR
2029	$76.50 – $112.20+5% CAGR	$367.79 – $539.43+32% CAGR	$91.26 – $133.85+5% CAGR
2030	$78.03 – $114.45+4% CAGR	$470.59 – $690.20+31% CAGR	$93.08 – $136.52+4% CAGR
2031	$79.59 – $116.74+4% CAGR	$602.12 – $883.11+30% CAGR	$94.95 – $139.25+4% CAGR
5-yr CAGR	-3.7% – 4.0%	20.8% – 30.4%	-3.7% – 4.0%